Above: A concentrated cone of blood cells forms in front of a capillary and results in single-file injection of the blood cells. Blood diagnostic kits cannot be scaled down further because of this curious phenomenon. MFA innovation may lead to exciting new approaches that enable additional miniaturization.

Microfluidic Applications engineers solutions to nanoscale biotech market needs by developing products with high commercial potential and providing industrial consulting services.

Vaccine preparation. Remote bacteria and virus sensors. Proteomic analysis. Medical diagnostic kits. Labs on a chip. Nanoparticle separations. All of these leading edge biotech applications require speed, precision, and reliability. Unfortunately, there are still technical bottlenecks that stand in the way of optimal performance. MFA will improve existing biotech products and commercialize new technologies that will make the largest of impacts on the smallest of scales.